Tolerability of cariprazine in the treatment of acute bipolar I mania: A pooled post hoc analysis of 3 phase II/III studies

Willie Earley; Suresh Durgam; Kaifeng Lu; M. Debelle; I. Laszlovszky; Eduard Vieta; Lakshmi N. Yatham

doi:10.1016/j.jad.2017.03.032

Back

Tolerability of cariprazine in the treatment of acute bipolar I mania: A pooled post hoc analysis of 3 phase II/III studies

Article 2017 en

Abstract

1 min read

Cariprazine was generally safe and well-tolerated in patients with manic/mixed episodes associated with bipolar I disorder.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2020

156 The Broad Efficacy of Cariprazine Across Symptoms in Patients with Bipolar I Disorder: Post Hoc Analysis of Randomized, Placebo-Controlled Trials

Lakshmi N. Yatham, Eduard Vieta, Roger S. McIntyre, Rakesh K. Jain, Willie Earley, Mehul Patel

Article2024

Impact of Predominant Polarity on Cariprazine Efficacy in Patients with Bipolar I Disorder: A Pooled Analysis

Eduard Vieta, Jun Yu, Huy‐Binh Nguyen, Lauren C. Aronin

Article2015

Effect of cariprazine across the symptoms of mania in bipolar I disorder: Analyses of pooled data from phase II/III trials

Eduard Vieta, Suresh Durgam, Kaifeng Lu, Adam Ruth, M. Debelle, Stephen R. Zukin

Article2021

Cariprazine‐induced mania: A case series report

María Teresa Pons-Cabrera, Roberto Palacios‐Garrán, Laia Tardón‐Senabre, Tabatha Fernández‐Plaza, Oriol Marco‐Estrada, Santiago Madero, Gerard Anmella, Lluc Colomer, Mauro Druetta, Anna Giménez‐Palomo, Lourdes Navarro‐Cortés, María Sagué‐Vilavella, Carlos Sánchez‐Sierra, Norma Verdolini, Rosa Catalán, Miquel Bioque, José Manuel Goikolea, Eduard Vieta, Isabella Pacchiarotti

Article2020

Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial

Lakshmi N. Yatham, Eduard Vieta, Willie Earley